Literature DB >> 6203634

Dynorphin and enkephalins in adrenal paraneurones. Opiates in the adrenal medulla.

S Lemaire, R Day, M Dumont, L Chouinard, R Calvert.   

Abstract

Immunoreactive dynorphin (ir-Dyn), immunoreactive leucine-enkephalin (ir-Leu-Enk) and various other neuropeptides were measured in acid extracts of bovine adrenal medulla and isolated adrenal chromaffin cells. Their respective levels ranged as follows: Leu-Enk greater than Dyn greater than bombesin greater than vasoactive intestinal peptide (VIP) greater than neurotensin greater than substance P. Comparisons of the total catecholamine levels with the levels of Leu-Enk in both extracts gave ratios in the same order of magnitude (2600, tissue extract and 5000, cell extract). However, the catecholamine/Dyn ratio in the tissue extract (138 000) was much higher than that found in the cell extract (20 180), suggesting a possible selective degradation of Dyn in tissue extract as compared with cell extract or an induction of Dyn biosynthesis in cells which have been isolated from their natural microenvironment. Immunofluorescence staining of isolated chromaffin cell sections revealed the presence of ir-Dyn in 5 to 10% of the total cell population. To localize ir-Dyn in regard to Leu-Enk and catecholamines, adrenal chromaffin cells were separated into three populations (I, II, and III) on a stepwise bovine serum albumin (BSA) gradient. Relative high levels of ir-Dyn were measured in cell layer I (4 pmol/10(6) cells), a cell population enriched in noradrenaline. However, ir-Leu-Enk was more concentrated in cell layers II and III (5.3 and 8.3 pmol/10(6) cells), two populations enriched in adrenaline. Isolation and high pressure liquid chromatography (HPLC) analysis of adrenomedullary Dyn indicated the presence of at least five molecular forms corresponding to Dyn-(1-11), Dyn-(1-12), Dyn-(1-13), Ala-containing-Dyn-(1-13) and a nonidentified molecule eluting closely to Dyn-(1-13). These data indicate that adrenal ir-Dyn and ir-Leu-Enk have distinct cellular distributions. In addition, the identification of Dyn fragments in bovine adrenal medulla indicates that these short peptides may be considered as natural active forms of Dyn.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203634     DOI: 10.1139/y84-078

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  7 in total

Review 1.  Role of neurotransmitters and neuropeptides in the regulation of the adrenal cortex.

Authors:  C Delarue; V Contesse; S Lenglet; F Sicard; V Perraudin; H Lefebvre; M Kodjo; F Leboulenger; L Yon; N Gallo-Payet; H Vaudry
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Studies on the adrenomedullary dependence of kappa-opioid agonist-induced diuresis in conscious rats.

Authors:  K R Borkowski
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

Review 3.  Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

Authors:  V K Shukla; S Lemaire
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

4.  Tissue-type plasminogen activator in rat adrenal medulla.

Authors:  P Kristensen; D M Hougaard; L S Nielsen; K Danø
Journal:  Histochemistry       Date:  1986

5.  Immunohistochemical localization of oxytocin and vasopressin in the adrenal glands of rat, cow, hamster and guinea pig.

Authors:  J Hawthorn; S S Nussey; J R Henderson; J S Jenkins
Journal:  Cell Tissue Res       Date:  1987-10       Impact factor: 5.249

Review 6.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

7.  Non-cholinergic component of rat splanchnic nerves predominates at low neuronal activity and is eliminated by naloxone.

Authors:  R K Malhotra; A R Wakade
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.